Login   |  Users Online: 64 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts


 
  Table of Contents  
CLINICAL RESEARCH
Year : 2015  |  Volume : 36  |  Issue : 4  |  Page : 404-409  

A placebo-controlled clinical evaluation of Kharjurapaka in Mamsakshaya


Department of Basic Principles, Institute for Postgraduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India

Date of Web Publication16-Sep-2016

Correspondence Address:
Sujata P Dhoke
PhD Scholar, Department of Basic Principles, IPGT and RA, Gujarat Ayurved University, Jamnagar - 361 008, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.190696

Rights and Permissions
   Abstract 

Introduction: The world is facing most of the health problems due to nutritional imbalance, and Mamsakshaya (wasting) is one of them. Mamsakshaya explained in Kiyantahshirasiya Adhyaya can be considered as a separate entity, and it can be correlated with Karshya vyadhi. Mamsakshaya occurs due to diminished Prithvi and Jala Mahabhuta in the body and also due to improper diet and environmental factors. Kharjurapaka (KP) is having Prithvi and Jala Mahabhuta dominance and Guru (heavy), Shita (cold), Snigdha (unctuous) Guna (property) which are similar to conjugation of Mamsa Dhatu. Aim: The aim of this study is to evaluate Brimhana (nourishment) effect of KP on having signs and symptoms of Mamsakshaya patients. Materials and Methods: The study was therapeutic, interventional, randomized placebo controlled clinical trial carried out on 34 patients of Mamsakshaya. Patients were divided into two Groups. In Group A (trial group), KP (20 g) once in a day with normal water was administered for 30 days, and in Group B (control group), placebo tablet (500 mg) of roasted wheat flour for 30 days duration was administered. Effect of therapy was assessed on subjective and objective parameters, anthropometrical parameters such as body mass index (BMI), weight, and chest circumference. Results: It was found that Group A showed significant results in BMI and sign and symptom of Mamsakshaya in comparison to Group B. Conclusion: KP showed better efficacy in comparison with placebo group.

Keywords: Bhrimhana, Kharjurapaka, Mamsakshaya, Karshya


How to cite this article:
Dhoke SP, Dwivedi R, Vyas M. A placebo-controlled clinical evaluation of Kharjurapaka in Mamsakshaya. AYU 2015;36:404-9

How to cite this URL:
Dhoke SP, Dwivedi R, Vyas M. A placebo-controlled clinical evaluation of Kharjurapaka in Mamsakshaya. AYU [serial online] 2015 [cited 2017 Jul 26];36:404-9. Available from: http://www.ayujournal.org/text.asp?2015/36/4/404/190696


   Introduction Top


Ahara (food) is one of the tripods of life as per Ayurveda classics.[1] The transforming unit from “food” into nutrition is called as “Agni” (digestive factors), which forms the basis upon which the Ayurveda system is built.[2] According to Charaka, Mamsakshaya (wasting) persons are considered under Ashtau-ninditiya Purusha (eight despicable persons)[3]Dalhana has described Karshya as the person having lean and thin body personality, who is a patient of Mamsakshaya.[4]

According to Ayurveda classics, Rukshannapana Sevana (indulgence of dry food items), Langhana (fasting), Pramitashana (less than normal quantity of diet) or diet that aggravates Vata (dry, astringent), Atishrama (excessive exercise), Atisnana (excess bath), Ruksha Udvartana (dry powder massage), Kriyatiyoga (excessive work), Chinta (worries), Bhaya (fear), Shrama (excessive physical and mental activity), Shoka (grief), Vega-Nidra-Trusha-Kshudha-Nigraha (suppression of natural urges, such as sleep, thirst, and hunger), Ati Maithuna (excessive sexual intercourse), Prakriti (constitution), Beeja Dosha (heredity), Jara (old age), Vikara anushaya (continued illness), and Krodha (anger) make person lean.[5] The Mamsakshaya person does not tolerate physical exercise, hunger, thirst, disease, and drugs.[6] The lean person has Shushka-Sphika, Shushka-Udara, Shushka-Greeva (emaciation of buttocks, abdomen, and neck), Vyayamam Atisauhityam (intolerance of physical exercise), Dhamanijal Santataha (prominent vascular network) Twagasthi shosha (remnant of skin and bone), Kshutpipasamay (suffering from hunger and thirst), Sthoolaparva (thick nodes), Atishitoshna-Maithunasahatva (cannot tolerate much cold, heat, and sexual intercourse).[7]

Mamsakshaya is Vata dominant disease. Treatments such as Bhrimhana and Rasayana have been advocated in the classics for its management. The selected drug Kharjura is described in Bhavaprakasha.[8] It has the property of Vatanulomana[9] and Bhrimhana.[10] The present study is aimed to evaluate the effect of Kharjurapaka (KP) on Mamsakshaya (lean) patients.


   Materials and Methods Top


Patients having the clinical features of “Mamsakshaya” such as Shushka-Sphika, Shushka-Udara, Shushka-Greeva (emaciation of buttocks, abdomen, and neck), Dhamani Jala Santataha (visible web of veins) Twagasthi shosha (remnant of skin and bone), Sthoolaparva (thick nodes), Glani (giddiness), and Alpa Nidra (inadequate sleep) attending the out patient department and inpatient department of the hospital were selected irrespective of caste, religion, occupation, and sex. The present clinical trial has been carried out after obtaining approval from Institutional Ethics Committee (No.: PGT/7-A/Ethics/2013-14/1767, Dated: September 10, 2013). The trial was registered in Clinical Trial Registry-India (CTRI/2015/07/006021, Dated: July 16, 2015). Written informed consent has been taken from all the patients before starting the trial. The study was designed as open-label, randomized placebo controlled clinical trial.

Inclusion criteria

  • Patients between 16 and 50 year age group without any bar of race, religion, and sex
  • Patients having low body weight (15–20% below than normal for their age and height) and lower body mass index (BMI) (under 18.5) with clinical features of Mamsa Dhatu Kshaya
  • Patients having proper Agnibala (digestive power) were selected.


Exclusion criteria

Patients having any systemic disease or history of chronic diseases such as tuberculosis, cancer, and autoimmune diseases which cause weight loss.

Grouping and posology

A total of 34 patients were registered for the present study, and coin toss method was adopted for randomization of patients. Patients were divided into two groups:

  1. Group A (treatment group): KP 20 g once in a day with normal water was administered for 30 days
  2. Group B (control group): Placebo tablet (500 mg) of roasted wheat flour was administered once in a day with normal water for 30 days.


Preparation method of Kharjurapaka

KP was prepared in the Department of Rasa Shastra and Bhaishajya Kalpana by following classical method of Paka preparation.[11]Kharjura (Phoenix dactylifera Linn.) was collected and its seeds were taken out. Kharjura pulp was made in to small pieces. Then, Kharjura and cow ghee were taken in the ratio of 10:1 and it was fried on mild temperature for 10–12 min and was stirred continuously so that it would not get scorched. As the fibril consistency was observed, then frying process was stopped and the process of preparation of Paka (in the form of Modaka) was done. Kharjura was procured from local market.

Investigations

Routine pathological tests such as (hemoglobin %, erythrocyte sedimentation rate, random blood sugar), urine (routine microscopic and macroscopic), stool (routine microscopic and macroscopic), and biochemical investigation (serum cholesterol, serum triglyceride, fasting blood sugar, high-density lipoprotein cholesterol, serum low-density lipoprotein, total protein, serum albumin to globulins ratio) were carried out to rule out any pathology before treatment.

Criteria for assessment of therapy

Subjective parameter

It has been mainly assessed on improvement in cardinal signs and symptoms of disease with the help of scoring pattern such as follows:

  1. Aayasa (lassitude)0: No Aayasa

    1: Little Aayasa in doing hard work

    2: Moderate Aayasa in doing hard work

    3: Excessive Aayasa in doing routine work.

  2. Glani (giddiness)0: No Glani at the level of physique, senses, and psyche

    1: Feel Glani at any level of physique but not appear on the face

    2: Little Glani at any level of physique, senses, and psyche

    3: Excessive Glani at any level of physique, senses, and psyche.

  3. Dhamani Jala Darshana (prominent vasculature)0: Not visible easily even after pressure

    1: Visible and prominent on pressure

    2: Visible

    3: Prominent.

  4. 4. Sthula Parva (knee, elbow, ankle, wrist joint)

    0: Deeply seated with extra fat

    1: Covered

    2: Prominent

    3: Relatively look larger.

    5. Kapola Gata Vasa (pad of fat on cheek)0: Cheeks everted

    1: On surface level

    2: Cheeks inside

    3: Cheeks inside with zygomatic bones prominent.

  5. 6. Daurbalya (fatigue)
  6. 0: Not feeling Daurbalya in doing any hard work1: Not feeling Daurbalya in doing easy work

    2: Feeling Daurbalya in doing little work

    3: Feel Daurbalya in rest position.

  7. 7. Shoka (grief)0: No sorrow even for reasonable cause

    1: Sorrowful only for reasonable cause

    2: Sorrowful even nonreasonable cause without anybody gesture

    3: Most sorrowful for no cause, unable to control his feelings, body gestures.

  8. 8. Nidra (sleep)0: 6–8 h deep sleep

    1: 6–8 h sleep but disturbed once

    2: <6 h sleep but disturbed twice

    3: <6 h sleep but disturbed frequently.


Objective parameter

Anthropometrical parameters such as BMI, weight, chest circumference, mid-arm circumference, and also skin fold thickness – biceps, triceps, and abdomen.

Statistical analysis

The statistical tests such as paired and unpaired t-test were applied for significance. Computer software SigmaStat (Systat Software, San Jose, California) was used for the calculation of statistical data.


   Observation Top


A total of 34 patients (17 in Group A and 17 in Group B) were registered in the trial, and out of which, 30 completed (15 in each group) the treatment. Age-wise distribution shows that 52.9% of the patients were between 16 and 25 years, 32.4% were in the age of 26–35 years, 14.7% were 36–50 years of age group. Majority of the patients, i.e., 67.6% were female while 32.4% were male. Maximum, i.e., 71% patients were taking vegetarian diet whereas 29% patients were taking mixed type of diet. The present study shows that maximum 76% patients were taking Katu Rasa Pradhana (pungent-dominant taste) diet whereas 74% patients had dominance of Lavana Rasa in their diet. Maximum 59% patients were taking Ruksha Guṇa Pradhana (dry-dominant property) diet whereas 47% patients were taking Ushna Guṇa Pradhana (hot-dominant property) diet and 44% patients were taking Sheeta Guna Pradhana (cold dominant property) diet. 41.18% patients had a habit of Divaswapa (daytime sleep) while 47.06% patients had a history of Ratrijagarana (late night sleep). Maximum, 58.83% patients, had the habit of Kshudha Vega Vidharana (suppression of hunger) whereas in 38.24% of the patients had a history of Trishna Vega Vidharana (suppression of thirst).


   Results Top


Effect of therapy on chief complaints

Group A depicted highly significant (P < 0.001) results in Aayasa, Glani, Daurbalya, Shoka, and Nidra and significant (P < 0.05) results in Dhamani Jala Darshana, Kapolgatavasa, and Sthula Parva [Table 1]. In Group B, highly significant (P < 0.001) effects on Aayasa, Daurbalya, Shoka, and Nidra and insignificant results depicted in Glani, Dhamani Jala Darshana, Kapolgatavasa, and Sthula Parva [Table 2].
Table 1: Effect of Kharjurapaka on Lakshanas of Mamsakshaya in Group A

Click here to view
Table 2: Effect of placebo tab on Lakshanas of Mamsakshaya in Group B

Click here to view


Effect of therapy on anthropometrical parameter and skin fold thickness

KP in Group A rendered highly significant (P < 0.001) results in reducing value of BMI, fat%, and weight, and placebo tablet in Group B rendered highly significant (P < 0.001) decrease in weight and insignificant change in BMI and fat% [Table 3] and [Table 4].
Table 3: Effect of Kharjurapaka on weight, fat%, and body mass index in Group A (n=15)

Click here to view
Table 4: Effects of placebo tablet on weight, fat%, body mass index in Group B (n=15)

Click here to view


Group A depicted significant (<0.01) results in reducing value in millimeter in chest circumference, forearm circumference, mid-arm circumference, mid-thigh circumference and insignificant result in mid-calf circumference [Table 5]. Group B rendered significant (<0.01) results in reducing value in millimeter in chest circumference, forearm circumference, mid-arm circumference, mid-thigh circumference, and mid-calf circumference [Table 6]. Group A depicted significant results in reducing value in millimeter in all the skin fold thickness (biceps, triceps, abdomen) and highly significant (<0.001) result in skin fold thickness of triceps and abdomen and significant result in reducing value in millimeter in skin fold thickness of biceps in Group B [Table 5] and [Table 6].
Table 5: Effect of Kharjurapaka on anthropometrical parameter and skin fold thickness in Group A (n=15)

Click here to view
Table 6: Effects of placebo tablet on anthropometrical parameters and skin fold thickness in Group B (n=15)

Click here to view


Comparative efficacy of therapy

In Glani and fat%, Group A had provided better results than Group B [Table 7]. The observations on contingency table were not significantly related as P value in comparative groups Group A and Group B (P > 0.05). This suggested that change occurred with the treatments was not enough to exclude the possibility that the difference was due to chance. Hence, both the groups have parallel effect on symptom of Mamsakshaya score of disease according to statistical analysis [Tables 8 and 9].
Table 7: Comparative efficacy of treated Group A with control Group B on Lakshanas of Mamsakshaya

Click here to view



   Discussion Top


Mamsa Dhatu Kshaya causes the increase of Vayu and Aakash Mahabhuta; consequently, this causes increase of Vata Dosha which is composed of these Mahabhutas.[12] Charaka has quoted that naming all types of diseases in definite terms is not possible, when aggravated the same Dosha may cause manifold diseases depending upon the various etiological factors and the sites of manifestation.[13] Hence, Mamsakshaya is taken as symptom and treated with KP. Similarly, in Mamsakshaya, there is a predominance of Vata Dosha which can be alleviated by the treatment of Brimhaniya Dravyas composed of Prithvi and Jala Mahabhuta. Ahara Dosha is the main predisposing factor for this disease and Alpashana and Vishamashana (improper diet) specially results in the advancement of Mamsakshaya. Pharmacotherapies such as Bhrimhana, Rasayana, and Vrishya have been advocated in the classics for the patients of Mamsakshaya. Madhura Rasa, Snigdha, Guru, Sthira Guna, Sheeta Virya of drugs gives relief to vitiated Vata Dosha. The ultimate aim of treating Mamsakshaya is to achieve a proportionate body. Probable mode of action of Bhrimhana Dravyas can be accessed on the ground of its property. It is found that the ingredient has predominance of Guru, Snigdha, Shita, and Manda Guna; Madhura Rasa and Madhura Vipaka lead to Vatanulomana and act as Bhrimhana.

Nutritional analysis of KP shows the presence of macronutrients such as energy (352.2 kcal), sugar (57.3 g), carbohydrate (77.6%w/w), protein (4.4%w/w), and fat (2.8%w/w)[14] for each 100 g sample. Major source of energy is macronutrients which are needed for growth, metabolism, and other body metabolism. The present result indicates the potentiality of KP as unconventional food. Kharjura is easily accessible and cheaper source of good nutrition. Vitamins C, Vitamins B1 thiamine, B2 riboflavin, nicotinic acid (niacin), and Vitamin A are present in Kharjura. Fourteen varieties of dates have been shown to be as high dietary fiber of 6.4–11.5%,[15] which depending on variety and degree of ripeness. Kharjura contains 0.5–3.9% pectin, which has valuable health benefits. These are attributed to the rich contents of antioxidant in date fruit such as ferulic acid and coumaric acid. Moreover, it contains procyanidins, flavonoids, sterols, sugar (glucose, sucrose, and fructose) carotenoids, anthocyanins, dietary fibers, thiamine, ascorbic, folic acid, and minerals such as cobalt magnesium, fluorine, manganese, calcium, iron, copper, phosphorus, boron, sulfur, zinc potassium, sodium, and selenium within the date palm itself.[16] Hence, Kharjura acts as a good nutritive fruit and also when it made with ghee, then the potency of drug increases.

Probable mode of action of Kharjurapaka

KP having a property of Madhura Rasa (sweet in taste) and Madhura Vipaka has diminished the Vata Dosha. Vatanulomana property of formulation helps in balance and maintenance of Agni and ultimately causes proper digestion of food. Guru, Shita, Snigdha, and Mrudu Gunas (soft property) are directly responsible for Bhrimhana effect.

KP having Prithvi and Jala Mahabhuta dominance is somewhat equivalent to property of Mamsa Dhatu; further, the available nutritive data of KP show it a competitive source of nutrition so it helps for nourishment of Mamsa Dhatu in better way. The Kharjura has maximum essential macronutrients and micronutrients. The prepared KP with ghee is a very well accepted for its palatability and taste.


   Conclusion Top


The present clinical study shows that the selected drug KP helps to improve the sign and symptoms of Mamsakshaya. KP showed marginal better in comparison with placebo control group. KP is useful for the treatment of Mamsakshaya.

Financial support and sponsorship

IPGT and RA, Gujarat Ayurved University, Jamnagar, Gujarat.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 11, Ver. 35. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 74.  Back to cited text no. 1
    
2.
Acharya YT, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana. Reprint Edition. Ch. 15, Ver. 3-4. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 512.  Back to cited text no. 2
    
3.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 19, Ver. 4. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 116.  Back to cited text no. 3
    
4.
Acharya YT, editor. Sushruta Samhita of Sushruta, Sutra Sthana. Reprint Edition. Ch. 15, Ver. 9. Varanasi: Choukhamba Surbharati Prakashana; 2008. p. 69.  Back to cited text no. 4
    
5.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 19, Ver. 11-12. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 117.  Back to cited text no. 5
    
6.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 19, Ver. 13. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 117.  Back to cited text no. 6
    
7.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 19, Ver. 15. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 118.  Back to cited text no. 7
    
8.
Mishra BS, editor. Bhavprakash Nighantu of Bhavmishra, Aamradi Phalavarga. Reprint Edition. 11th ed., Ver. 115. Varanasi: Chaukhambha Sanskrit Sansthan; 2004. p. 587.  Back to cited text no. 8
    
9.
Javalgekar RR, Deshpande AP. Textbook of Dravyagunavijnana. Reprint Edition. Pune: Profishanta Publishing House; 2013. p. 914.  Back to cited text no. 9
    
10.
Anonymous. The Ayurvedic Pharmacopeia of India. 1st ed., Vol. 4. New Delhi: Department of AYUSH, Ministry of Welfare and FW, GOI; 2007. p. 45-6.  Back to cited text no. 10
    
11.
Tripathi B, editor. Sharangdhara Samhita of Pandita Sharangdhara, Khanda. Reprint Edition. Ch. 4 Ver. 29. Varanasi: Choukhamba Surbharati Prakashana; 2010. p. 346.  Back to cited text no. 11
    
12.
Sharma SP, editor. Astangasamgraha of Vagbhata Sutra Sthana. Reprint Edition. Ch. 20, Ver. 2. Varanasi: Chowkhamba Sanskrit Series Office; 2008. p. 156.  Back to cited text no. 12
    
13.
Acharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Reprint Edition. Ch. 18, Ver. 44. Varanasi: Chaukhamba Sanskrit Sansthana Prakashan; 2011. p. 108.  Back to cited text no. 13
    
14.
Dhoke SP, Dwivedi RR, Vyas MK, Ghuse R, Sah MK. Nutritional evaluation of Kharjurapaka. Int J Res Altern Med 2015;2:16-21.  Back to cited text no. 14
    
15.
Al-Shahib W, Marshall RJ. The fruit of the date palm: Its possible use as the best food for the future? Int J Food Sci Nutr 2003;54:247-59.  Back to cited text no. 15
    
16.
Anjum FM, Bukhat SI, El-Ghorab AH, Khan MI, Nadeem M, et al. Phytochemical characteristics of date palm (Phoenix dactylifera) fruit extracts. Pak J Food Sci 2012;22: 117-27.  Back to cited text no. 16
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8], [Table 9]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
    Materials and Me...
   Observation
   Results
   Discussion
   Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed1317    
    Printed11    
    Emailed0    
    PDF Downloaded135    
    Comments [Add]    

Recommend this journal